Third Rock Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
30
- Investments
-
149
- Portfolio
-
18
- Exits
-
103
Third Rock Ventures General Information
Company Description
Founded in 2007, Third Rock Ventures is a venture capital firm headquartered in Boston, Massachusetts. The firm seeks to invest in companies operating in the healthcare, medicine, life sciences, drugs, devices, diagnostics, therapeutics, and information technology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.thirdrockventures.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 201 Brookline Avenue
- Suite 1401
- Boston, MA 02215
- United States
Third Rock Ventures Investments (149)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Marea | 17-Sep-2026 | PIPE | Biotechnology | Clinical Trials - Phase 2 | ||
| Flare Therapeutics | 30-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Terremoto Biosciences | 15-Apr-2026 | Drug Delivery | Generating Revenue | |||
| Syremis Therapeutics | 02-Dec-2025 | Biotechnology | Pre-Clinical Trials | |||
| Azalea Therapeutics | 30-Oct-2025 | Biotechnology | Startup | |||
| Artbio | 29-Jul-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Corvia Medical (Therapeutic Devices) | 17-Jun-2025 | Therapeutic Devices | Generating Revenue | |||
| Merida Biosciences | 08-Apr-2025 | Drug Discovery | Clinical Trials - General | |||
| Maze Therapeutics | 26-Nov-2024 | Later Stage VC | Drug Discovery | Profitable | ||
| Trace Neuroscience | 12-Nov-2024 | Early Stage VC | Laboratory Services (Healthcare) | Generating Revenue |
Third Rock Ventures Exits (103)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Marea | 17-Sep-2026 | Reverse Merger | |
| Merida Biosciences | 31-Aug-2026 | ||
| Seaport Therapeutics | 01-May-2026 | ||
| Abata Therapeutics | 09-Apr-2026 | ||
| EveryONE Medicines | 03-Mar-2026 | ||
| Candid Therapeutics | 01-Mar-2026 | ||
| YourBio Health | 01-Jan-2026 | ||
| Faze Medicines | 12-Oct-2025 | ||
| Rapport Therapeutics | 11-Sep-2025 | Public Investment 2nd Offering | |
| Cargo Therapeutics | 18-Aug-2025 | Merger/Acquisition |
Third Rock Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Third Rock Ventures Investments by Industry, Year, and Region
Third Rock Ventures Co-Investors (133)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GV | 6 |
|
|
||
| Casdin Capital |
|
|
|||
| Cormorant Asset Management |
|
|
|||
| RA Capital Management |
|
|
|||
| Goldman Sachs Asset Management |
|
|
Third Rock Ventures FAQs
-
What is Third Rock Ventures?
Founded in 2007, Third Rock Ventures is a venture capital firm headquartered in Boston, Massachusetts.
-
When was Third Rock Ventures founded?
Third Rock Ventures was founded in 2007.
-
Where is Third Rock Ventures headquartered?
Third Rock Ventures is headquartered in Boston, MA.
-
What is Third Rock Ventures's total asset value?
Third Rock Ventures has around in total assets under management.
-
How many investments has Third Rock Ventures made?
Third Rock Ventures has made 149 investments.
-
What has Third Rock Ventures invested in?
Third Rock Ventures has made numerous investments in companies like Marea, Flare Therapeutics, and Terremoto Biosciences within the Biotechnology, Drug Discovery, and Drug Delivery industries.
-
What has Third Rock Ventures invested in recently?
Third Rock Ventures's latest investment was on 17-Sep-2026 in Marea, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process